Literature DB >> 29334503

Family history of autoimmune diseases and risk of gastric cancer: a national cohort study.

Jianguang Ji1, Jan Sundquist1,2, Kristina Sundquist1,2.   

Abstract

A personal history of autoimmune diseases is associated with an increased incidence of gastric cancer, but whether they share familial susceptibility is still unknown. The contribution of shared environmental or genetic factors toward the observed familial aggregation has not been determined. We used a few Swedish registers, including the Swedish Multigeneration Register and the Cancer Register, to examine the familial risk of gastric cancer among individuals with a family history of a set of autoimmune diseases. Standardized incidence ratios were used to calculate the relative risk. The overall risk of gastric cancer was 1.22 (95% confidence interval: 1.14-1.30) among individuals with a sibling affected with any of the 33 autoimmune diseases. For specific disease, siblings of individuals with Crohn's diseases, diabetes type 1, Graves'/hyperthyroidism, myasthenia gravis, psoriasis, rheumatoid arthritis, sarcoidosis, and uncreative colitis showed an association with an increased incidence of gastric cancer, with a standardized incidence ratio ranging between 1.17 and 1.64. Familial aggregation was found only for corpus cancer. No association was observed between spouses. Gastric cancer, mainly corpus cancer, shares familial susceptibility with a few autoimmune diseases, suggesting that shared genetic polymorphisms may contribute toward both Helicobacter pylori infection and autoimmune diseases.

Entities:  

Mesh:

Year:  2018        PMID: 29334503     DOI: 10.1097/CEJ.0000000000000420

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  2 in total

1.  Six Autoimmune Disorders Are Associated With Increased Incidence of Gastric Cancer: A Systematic Review and Meta-Analysis of Half a Million Patients.

Authors:  Noémi Zádori; Lajos Szakó; Szilárd Váncsa; Nóra Vörhendi; Eduard Oštarijaš; Szabolcs Kiss; Levente Frim; Péter Hegyi; József Czimmer
Journal:  Front Immunol       Date:  2021-11-23       Impact factor: 7.561

2.  Hyperthyroidism is not a significant risk of benign prostatic hyperplasia: A nationwide population-based study.

Authors:  Kee-Ming Man; Kuen-Bao Chen; Huey-Yi Chen; Jen-Huai Chiang; Yuan-Chih Su; Samantha S Man; Dong-Dong Xie; Yi Wang; Zhi-Qiang Zhang; Liang-Kuan Bi; Tao Zhang; De-Xin Yu; Wen-Chi Chen
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.